Manuscripts
Showing 1591 manuscripts.
Cognitive Behavioral Therapy Factors Related to Outcomes in Depression Among Youth with HIV
Citation
Betsy D. Kennard, Larry K. Brown, Kristin Baltrusaitis, Miriam Chernoff, Graham J. Emslie, Jessica Jones, Sarah Buisson, Jaime Deville, Megan Wilkins, Amber Bunch, Chivon McMullen Jackson, Christy Beneri, David E. Shapiro, IMPAACT 2002 Team. Cognitive Behavioral Therapy Factors Related to Outcomes in Depression Among Youth with HIV. Cognitive Therapy and Research. 2024 Aug 01; 48(4):781-790. PMID: 39664885; PMCID: PMC11634056.Year
2024
Journal
Cognitive Therapy and Research
Study
IMPAACT 2002
Maternal immunity shapes biomarkers of germinal center development in HIV-exposed uninfected infants
Citation
John W. Sleasman, Guglielmo M. Venturi, Bernard M. Fischer, Julie J. Kim-Chang, Richard Barfield, Cliburn Chan, Kristina De Paris, Li Yin, Maureen M. Goodenow. Maternal immunity shapes biomarkers of germinal center development in HIV-exposed uninfected infants. Frontiers in Immunology. 2024 Sep 12; 15:1443886. PMID: 39328414; PMCID: 11424517.Year
2024
Journal
Frontiers in Immunology
Maternal-Child Human Immunodeficiency Virus Clinical Trials Networks across the Ages
Citation
Sharon Nachman. Maternal-Child Human Immunodeficiency Virus Clinical Trials Networks across the Ages. Clinics in Perinatology. 2024 Dec 02; 51(4):935-949. PMID: 39487030; PMCID: PMC11531646.Year
2024
Journal
Clinics in Perinatology
Pharmacokinetics and Safety of Remdesivir in Pregnant and Nonpregnant Women With COVID-19: Results From IMPAACT 2032
Citation
Kristina M. Brooks, Kristin Baltrusaitis, Diana F. Clarke, Sharon Nachman, Jennifer Jao, Murli U. Purswani, Allison Agwu, Christy Beneri, Jaime G. Deville, Kathleen M. Powis, Alice M. Stek, Ahizechukwu C. Eke, David E. Shapiro, Edmund Capparelli, Elizabeth Greene, Kathleen George, Dwight E. Yin, Patrick Jean-Philippe, Nahida Chakhtoura, Frederic Bone, Kira Bacon, Benjamin Johnston, Christina Reding, Kathryn Kersey, Rita Humeniuk, Brookie M. Best, Mark Mirochnick, Jeremiah D. Momper, IMPAACT 2032 Study Team. Pharmacokinetics and Safety of Remdesivir in Pregnant and Nonpregnant Women With COVID-19: Results From IMPAACT 2032. Journal of Infectious Diseases. 2024 Oct 16; 230(4):878-888. PMID: 38839047; PMCID: PMC11481345.Year
2024
Journal
Journal of Infectious Diseases
Study
IMPAACT 2032
Infectivity and Immunogenicity of Live-Attenuated Respiratory Syncytial Virus Vaccines in Human Immunodeficiency Virus-Exposed Uninfected Children
Citation
Matthew S. Kelly, Coleen K. Cunningham, Elizabeth J. McFarland, Mark J. Giganti, Jane C. Lindsey, Charlotte Perlowski, Jennifer L. Libous, Patrick Jean-Philippe, Jack Moye, Ruth A. Karron, Peter L. Collins, Ursula J. Buchholz. Infectivity and Immunogenicity of Live-Attenuated Respiratory Syncytial Virus Vaccines in Human Immunodeficiency Virus-Exposed Uninfected Children. Open Forum Infectious Diseases. 2024 Nov 13; 11(12):ofae679. PMID: 39610407; PMCID: PMC11604081.Year
2024
Journal
Open Forum Infectious Diseases
Study
P1114, IMPAACT 2000, IMPAACT 2011, IMPAACT 2012, IMPAACT 2013, IMPAACT 2018
Infants Receiving Very Early ART Have High CD4 Counts in the First Year of Life
Citation
Bryan S. Nelson, Camlin Tierney, Deborah Persaud, Jennifer Jao, Mark F. Cotton, Yvonne Bryson, Anne Coletti, Theodore D. Ruel, Stephen A. Spector, Christina Reding, Kira Bacon, Diane Costello, Charlotte Perlowski, Maria Leticia Santos Cruz, Josphat Kosgei, Sai Majji, Dwight E. Yin, Patrick Jean-Philippe, Ellen G. Chadwick, IMPAACT P1115 Team. Infants Receiving Very Early ART Have High CD4 Counts in the First Year of Life. Clinical Infectious Diseases. 2023 Feb 08; 76(3):e744-e747. PMID: 36031390.Year
2023
Journal
Clinical Infectious Diseases
Study
P1115
Pharmacokinetics, tolerability, and safety of doravirine and doravirine/lamivudine/tenofovir disoproxil fumarate fixed dose combination tablets in adolescents living with HIV: Week 24 results from IMPAACT 2014
Citation
Ann J Melvin, Ka Lai Yee, Kathryn P Gray, Mounika Yedla, Hong Wan, Nicole H. Tobin, Hedy Teppler, Havilland Campbell, Katie McCarthy, Rachel Scheckter, Linda Aurpibul, Pradthana Ounchanum, Supattra Rungmaitree, Hassena Cassim, Elizabeth McFarland, Patricia Flynn, Ellen Cooper, Chelsea Krotje, Ellen Townley, Jack Moye, Brookie M. Best, IMPAACT 2014 Study Team. Pharmacokinetics, tolerability, and safety of doravirine and doravirine/lamivudine/tenofovir disoproxil fumarate fixed dose combination tablets in adolescents living with HIV: Week 24 results from IMPAACT 2014. Journal of AIDS. 2023 Feb 01; PMID: 36215957; PMCID: PMC9839475.Year
2023
Journal
Journal of AIDS
Study
IMPAACT 2014
Self-reported Antiretroviral Adherence: Association With Maternal Viral Load Suppression in Postpartum Women Living With HIV-1 From Promoting Maternal and Infant Survival Everywhere, a Randomized Controlled Trial in Sub-Saharan Africa and India
Citation
Neetal Nevrekar, Kevin Butler, David E. Shapiro, Patience Atuhaire, Taha E Taha, Bonus Makanani, Lameck Chinula, Maxensia Owor, Dhayendre Moodley, Tsungai Chipato, Katie McCarthy, Patricia M. Flynn, Judith Currier, Mary Glenn Fowler, Amita Gupta, Nishi Suryavanshi. Self-reported Antiretroviral Adherence: Association With Maternal Viral Load Suppression in Postpartum Women Living With HIV-1 From Promoting Maternal and Infant Survival Everywhere, a Randomized Controlled Trial in Sub-Saharan Africa and India. Journal of the International AIDS Society. 2023 Dec 31; 92(1):76-83. PMID: 36170749; PMCID: PMCID: PMC9722360.Year
2023
Journal
Journal of the International AIDS Society
Study
1077FF, 1077BF
Physiologically-based pharmacokinetic modeling of remdesivir and its metabolites in pregnant women with COVID-19
Citation
Xiaomei Liu, André Dallmann, Kristina Brooks, Brookie M Best, Diana F Clarke, Mark Mirochnick, John N van den Anker, Edmund V Capparelli, Jeremiah D Momper. Physiologically-based pharmacokinetic modeling of remdesivir and its metabolites in pregnant women with COVID-19. CPT: pharmacometrics & systems pharmacology. 2023 Feb 01; 12(2):148-153. PMID: 36479969; PMCID: PMC9877749.Year
2023
Journal
CPT: pharmacometrics & systems pharmacology
Study
IMPAACT 2032
Prevalence of neurotoxicity symptoms among postpartum women on isoniazid preventive therapy and efavirenz-based treatment for HIV: an exploratory objective of the IMPAACT P1078 randomized trial
Citation
Patricia Mandima, Kristin Baltrusaitis, Grace Montepiedra, Lisa Aaron, Jyoti Mathad, Carolyne Onyango-Makumbi, Mandisa Nyati, James Ngocho, Gift Chareka, Ponego Ponatshego, Gaerolwe Masheto, Katie McCarthy, Patrick Jean-Philippe, Amita Gupta, Lynda Stranix-Chibanda, IMPAACT P1078 TB APPRISE study team. Prevalence of neurotoxicity symptoms among postpartum women on isoniazid preventive therapy and efavirenz-based treatment for HIV: an exploratory objective of the IMPAACT P1078 randomized trial. Journal of Acquired Immune Deficiency Syndromes. 2023 Jan 17; PMID: 36650479; PMCID: PMC9847058.Year
2023
Journal
Journal of Acquired Immune Deficiency Syndromes
Study
P1078